Single-agent and combination chemotherapy with etoposide in the acute leukemias of childhood
- 30 June 1982
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 9, 53-57
- https://doi.org/10.1016/s0305-7372(82)80078-9
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemiaCancer, 1980
- Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemiaCancer, 1980
- Recurrent childhood lymphocytic leukemia. Clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remissionCancer, 1978
- 5-azacytidine in acute leukemiaCancer, 1978
- VM 26 and VP 16–213: A comparative analysisCancer, 1977
- VP 16-213 in acute myelogenous leukaemiaPublished by Oxford University Press (OUP) ,1976
- Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotoxin glucopyranoside derivativesEuropean Journal of Cancer (1965), 1975
- Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213European Journal of Cancer (1965), 1975
- Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomasCancer, 1974
- 4′-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of actionEuropean Journal of Cancer (1965), 1970